- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Australian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
3
0 new
High return on equity, past performance and sound balance sheet.
3 companies
EZZ Life Science Holdings
Market Cap: AU$70.8m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.50
7D
-4.2%
1Y
37.0%
Cryosite
Market Cap: AU$36.4m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$0.74
7D
-0.7%
1Y
-29.0%
NeuroScientific Biopharmaceuticals
Market Cap: AU$8.1m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.056
7D
-3.4%
1Y
19.1%